These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 29517279

  • 1. Association of serum procalcitonin level with in-stent restenosis in patients undergoing bare-metal stent implantation.
    Ornek E, Cetin M, Kiziltunc E, Kurtul A, Gok M, Kundi H.
    Biomark Med; 2018 May; 12(5):455-463. PubMed ID: 29517279
    [Abstract] [Full Text] [Related]

  • 2. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
    Murat SN, Yarlioglues M, Celik IE, Kurtul A, Duran M, Kilic A, Oksuz F.
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
    [Abstract] [Full Text] [Related]

  • 3. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

  • 4. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
    Celik IE, Yarlioglues M, Kurtul A, Duran M, Koseoglu C, Oksuz F, Aksoy O, Murat SN.
    Angiology; 2016 May; 67(5):478-83. PubMed ID: 26243483
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
    Kurtul A.
    Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
    [Abstract] [Full Text] [Related]

  • 6. Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis.
    Canpolat U, Turak O, Özcan F, Öksüz F, Mendi MA, Yayla Ç, Aydoğdu S.
    Arch Endocrinol Metab; 2017 May; 61(2):130-136. PubMed ID: 28489156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
    Yoshimura M, Umemoto S, Kawano R, Hiromoto M, Yamada M, Fujimura T, Tanaka M, Nao T, Miura T, Yano M.
    Int Heart J; 2021 May; 62(5):970-979. PubMed ID: 34588411
    [Abstract] [Full Text] [Related]

  • 12. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [Abstract] [Full Text] [Related]

  • 13. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 14. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
    Drozd J, Wójcik J, Małek R, Korona B, Zapolski T, Wysokiński A.
    Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
    [Abstract] [Full Text] [Related]

  • 15. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J, Kozuma K, Mitsudo K.
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [Abstract] [Full Text] [Related]

  • 16. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R, von Felten S, Wein B, Tueller D, Kurz DJ, Reho I, Galatius S, Alber H, Conen D, Pfisterer M, Kaiser C, Eberli FR.
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [Abstract] [Full Text] [Related]

  • 17. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ, Melbourne Interventional Group (MIG) Investigators.
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
    Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K.
    J Cardiol; 2013 Feb; 61(2):117-21. PubMed ID: 23159206
    [Abstract] [Full Text] [Related]

  • 19. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [Abstract] [Full Text] [Related]

  • 20. Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
    Demirbag R, Sezen Y, Yeşilay AB, Bas M, Yildiz A, Guntekin U, Aksoy N.
    Coron Artery Dis; 2011 Aug; 22(5):289-93. PubMed ID: 21394024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.